Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Danaher to buy Cepheid in $4 billion deal

Danaher Corp. said it would buy medical diagnostics company Cepheid in a deal valued at $4 billion that will strengthen its presence in molecular diagnostics.

Read More »

Tonix to stop testing drug for fibromyalgia

Tonix Pharmaceuticals Holding Corp. said it would stop developing its drug for fibromyalgia after the treatment failed in a late-stage trial.

Read More »

GSK’s triple drug cuts flare-ups in chronic lung disease

An experimental three-in-one inhaled drug from GlaxoSmithKline significantly cut flare-ups in patients with chronic lung disease in a clinical trial, researchers said.

Read More »

SEC Filings Show How Medivation’s CEO and Board Backroom Dealings Drove Up Acquisition Price

Now that the Pfizer acquisition of Medivation is basically a done deal, more details are coming out about how the deal went down and Medivation chief executive officer David Hung’s share of the winnings.

Read More »

New Research From Kantar Health Shows High BMI Is Less Of A Factor For Developing Diabetes

Most patients diagnosed with type 2 diabetes in Japan are not classified as overweight or obese according to new research conducted by Kantar Health, a leading global healthcare consulting and research firm.

Read More »

Research links eczema and hay fever to early antibiotic use

Babies given antibiotics in the first two years of life are more likely to develop allergies as adults, according to an extensive analysis of past clinical studies involving nearly 400,000 people.

Read More »

Vitamin D tablets may help reduce asthma attacks, review finds

The world’s 300 million asthma sufferers could help reduce their risk of severe asthma attacks by taking vitamin D supplements as well as their standard asthma medicines, according to the findings of a review of international trial evidence.

Read More »

FDA halts sale of some over-the-counter hand, body wash products

The U.S. Food and Drug Administration halted the sale of some antibacterial over-the-counter hand and body wash products, saying they were not more effective than plain soap and water in preventing illnesses and reducing the spread of infections.

Read More »

Dogs use same parts of brain to process speech as humans, Hungarian study says

A group of Hungarian researchers at the Eotvos Lorand University in Budapest have scanned the brains of 13 dogs, finding that dogs process words and intonation to work out messages similarly to humans.

Read More »

U.S. fights Zika mosquitoes with limited arsenal

The arrival in Florida of Zika, a virus that can cause a crippling birth defect known as microcephaly, has drawn into focus the limitations of the U.S. mosquito control arsenal.

Read More »

Merck scraps development of osteoporosis drug

Merck & Co. Inc. said it would stop developing its experimental osteoporosis drug after an independent analysis confirmed the treatment raises the risk of stroke.

Read More »

Arena Forms Drug Discovery Incubator

San Diego-based Arena Pharmaceuticals announced that it had created an independent, privately held drug discovery incubator called Beacon Discovery.

Read More »

FDA Approves BLINCYTO For Use In Pediatric Patients With Philadelphia Chromosome-Negative Relapsed Or Refractory B-cell Precursor Acute Lymphoblastic Leukemia

Amgen announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Application for BLINCYTO (blinatumomab) to include new data supporting the treatment of pediatric patients with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia.

Read More »

Takeda to develop Zika vaccine with U.S. funding

Japanese drugmaker Takeda Pharmaceutical Co. said it is developing a vaccine to prevent the Zika virus, which has been linked to severe birth defects, and has secured funding from a U.S. government agency.

Read More »

Novo Nordisk’s veteran CEO to step down

Novo Nordisk’s chief executive Lars Rebien Sorensen is to step down at a time when the world’s largest insulin maker has said it faces increased U.S. competition.

Read More »

Juno, Kite Pharma Fall After Novartis Dissolves CAR-T Unit

Novartis AG’s dissolving of its Gene and Cell Therapy Unit sent ripples across the CAR-T company market, causing shares of Juno Therapeutics and Kite Pharma to drop in trading.

Read More »

Parexel Loses $160 Million in Value in One Day After Disclosing Possible ‘Misappropriation of Corporate Funds’

Shares of contract research organization Parexel dropped nearly 5 percent in one day, causing the company to lose about $160 million in value after the company announced it was delaying filing its 10-K following the discovery of the misappropriation of funds by an employee.

Read More »

Roche’s new-drug strategy buoyed by lung-cancer study

Swiss drugmaker Roche Holding AG, seeking to expand uses for its drug Tecentriq beyond bladder cancer, said a study had shown the new immunotherapy helped people with lung cancer live longer than with chemotherapy.

Read More »

Nestle to buy medical device company Phagenesis

Nestle to buy Phagenesis, a British medical device company working on a new treatment for dysphagia, a condition where patients are unable to swallow safely.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!


Ad Right Bottom